AbbVie Announces Availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the Treatment of Platinum-Resistant Ovarian Cancer
ELAHERE is the first and only antibody-drug conjugate (ADC) therapy approved specifically for patients with folate receptor alpha (FRα) positive, platinum-resistant high grade serous epithelial ovarian cancer, fallopian tube or primary peritoneal...
GIGABYTE Announces Availability of 27" QHD 240Hz WOLED Gaming Monitor for Competitive Play
TAIPEI, May 14, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, announces the availability of the GO27Q24G WOLED gaming monitor. This 4-sided borderless 27-inch QHD display features a 240Hz refresh rate with NVIDIA® G-SYNC®...